4//SEC Filing
Kharabi Darius 4
Accession 0001415889-23-000641
CIK 0001479419other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 8:00 PM ET
Size
5.7 KB
Accession
0001415889-23-000641
Insider Transaction Report
Form 4
Kharabi Darius
CHIEF BUSINESS OFFICER
Transactions
- Award
Common Stock
2023-01-04+9,525→ 15,439 total
Footnotes (3)
- [F1]Grant of restricted stock units ("RSUs") under the Issuer's 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the Reporting Person's continued employment with Issuer, the RSUs will vest as to 1/3 of the shares underlying the RSUs on January 4, 2024, as to 1/3 of the shares underlying the RSUs on January 4, 2025 and as to the final 1/3 of shares underlying the RSUs on January 4, 2026.
- [F2]Includes 9,525 unvested RSUs and 1,294 shares of the Issuer's common stock issuable to the Reporting Person in connection with the Issuer's acquisition of Combangio, Inc. and which are being held back by the Issuer until February 15, 2023 as partial security for the satisfaction of indemnification obligations and other payment obligations of the former Combangio equityholders.
- [F3]The number of shares of common stock reported on this Form 4 reflects a 1-for-50 reverse stock split effected by the Issuer on October 20, 2022.
Documents
Issuer
Kala Pharmaceuticals, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001893729
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 8:00 PM ET
- Size
- 5.7 KB